Comparison of neointimal coverage between ultrathin biodegradable polymer-coated sirolimus-eluting stents and durable polymer-coated everolimus-eluting stents: 6 months optical coherence tomography follow-up from the TAXCO study

被引:13
|
作者
Abhyankar, Atul [1 ]
Abizaid, Alexandre [2 ]
Chamie, Daniel [3 ]
Rathod, Mihir [1 ]
机构
[1] Shree BD Mehta Mahavir Heart Inst, Dept Cardiol, Surat, Gujarat, India
[2] Univ Sao Paulo, Intervent Cardiol Dept, Sao Paulo, Brazil
[3] Dante Pazzanese Inst Cardiol, Invas Cardiol Dept, Sao Paulo, Brazil
关键词
coronary artery disease; drug-eluting stent; everolimus; percutaneous coronary intervention; sirolimus; PERCUTANEOUS CORONARY INTERVENTION; VASCULAR-RESPONSE; STRUT THICKNESS; THROMBOSIS; ANGIOGRAPHY; MECHANISMS; PATHOLOGY; IMPACT; RISK;
D O I
10.1002/ccd.28833
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim The TAXCO study was designed to compare the degree of neointimal coverage and the prevalence of malapposition at 6 months subsequent to implantation of ultrathin biodegradable polymer-coated sirolimus-eluting stents (SES) and durable polymer-coated everolimus-eluting stents (EES) of thin strut thickness using optical coherence tomography (OCT). Methods The TAXCO study included a total of 42 patients who gave consent and underwent OCT examination between August 2017 and September 2017. Of 42, five patients' OCT examinations were of insufficient quality for quantitative analysis. Thus, the OCT analysis group consisted of 37 patients. Among them, 16 patients were treated with Xience (Abbott Vascular) and 21 with Tetriflex (Sahajanand Medical Technologies Pvt. Ltd., Surat, India), 6 (+/- 1) months earlier at our institution. The OCT was performed using a C7 Dragonfly (TM) imaging catheter (St. Jude Medical Inc.). All OCT images were analyzed at an independent core laboratory (Cardiovascular Research Center, Sao Paulo, Brazil) by analysts who were blinded to patient and procedural information. Results A total of 763 crosssections (6,882 struts) were analyzed in Xience group, and 1,127 crosssections (9,968 struts) in Tetriflex group. At 6 months, on per-lesion basis, no significant differences were observed between Xience group and Tetriflex group in mean percentage of uncovered struts (1.87 +/- 3.86 vs. 2.42 +/- 3.46, p = .137) and malapposed struts (0.05 +/- 0.2 vs. 0.21 +/- 0.69, p = .302). Strut-level neointimal thickness also did not differ between Xience group and Tetriflex group (0.18 +/- 0.12 vs. 0.14 +/- 0.08 mm, p = .286). Conclusion This OCT study found no significant difference in strut coverage and neointimal thickness at 6 months after implantation of biodegradable polymer-coated Tetriflex, when compared with durable polymer-coated Xience.
引用
收藏
页码:423 / 430
页数:8
相关论文
共 50 条
  • [31] Randomized comparison of biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for percutaneous coronary revascularization: Rationale and design of the BIOSCIENCE trial
    Pilgrim, Thomas
    Roffi, Marco
    Tueller, David
    Muller, Olivier
    Vuilliomenet, Andre
    Cook, Stephane
    Weilenmann, Daniel
    Kaiser, Christoph
    Jamshidi, Peiman
    Heg, Dik
    Jueni, Peter
    Windecker, Stephan
    AMERICAN HEART JOURNAL, 2014, 168 (03) : 256 - 261
  • [32] Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for primary percutaneous coronary revascularisation of acute myocardial infarction
    Pilgrim, Thomas
    Piccolo, Raffaele
    Heg, Dik
    Roffi, Marco
    Tuller, David
    Vuilliomenet, Andre
    Muller, Olivier
    Cook, Stephane
    Weilenmann, Daniel
    Kaiser, Christoph
    Jamshidi, Peiman
    Khattab, Ahmed A.
    Taniwaki, Masanori
    Rigamonti, Fabio
    Nietlispach, Fabian
    Blochlinger, Stefan
    Wenaweser, Peter
    Juni, Peter
    Windecker, Stephan
    EUROINTERVENTION, 2016, 12 (11) : E1343 - E1354
  • [33] Gender difference on five-year outcomes of EXCEL biodegradable polymer-coated sirolimus-eluting stents implantation: results from the CREATE study
    Zhang Lei
    Qiao Bing
    Han Ya-ling
    Li Yi
    Xu Kai
    Zhang Quan-yu
    Yang Li-xia
    Liu Hui-liang
    Xu Bo
    Gao Run-lin
    CHINESE MEDICAL JOURNAL, 2013, 126 (06) : 1039 - 1045
  • [34] Early Vascular Healing Following Bioresorbable-Polymer Sirolimus-Eluting Stent Placement Compared to That with Durable-Polymer Everolimus-Eluting Stent Sequential Optical Coherence Tomography Study
    Ogura, Kunihiro
    Tsujita, Hiroaki
    Oishi, Yosuke
    Matsumoto, Hidenari
    Matsukawa, Naoki
    Sakai, Rikuo
    Arai, Taito
    Sato, Shunya
    Tanaka, Hideaki
    Masaki, Ryota
    Arai, Ken
    Nomura, Kosuke
    Kosaki, Ryota
    Sakai, Koshiro
    Sekimoto, Teruo
    Kondo, Seita
    Tsukamoto, Shigeto
    Mori, Hiroyoshi
    Yamamoto, Myong Hwa
    Wakabayashi, Kohei
    Suzuki, Hiroshi
    Ochiai, Masahiko
    Shinke, Toshiro
    INTERNATIONAL HEART JOURNAL, 2021, 62 (03) : 510 - 519
  • [35] Long-term coronary arterial response to biodegradable polymer biolimus-eluting stents in comparison with durable polymer sirolimus-eluting stents and bare-metal stents: Five-year follow-up optical coherence tomography study
    Kuramitsu, Shoichi
    Sonoda, Shinjo
    Yokoi, Hiroyoshi
    Iwabuchi, Masashi
    Nishizaki, Yuji
    Shinozaki, Tomohiro
    Domei, Takenori
    Hyodo, Makoto
    Inoue, Katsumi
    Shirai, Shinichi
    Ando, Kenji
    Nobuyoshi, Masakiyo
    ATHEROSCLEROSIS, 2014, 237 (01) : 23 - 29
  • [36] Five-Year Outcomes in Patients With Diabetes Mellitus Treated With Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents
    Iglesias, Juan F.
    Heg, Dik
    Roffi, Marco
    Tuller, David
    Lanz, Jonas
    Rigamonti, Fabio
    Mueller, Olivier
    Moarof, Igal
    Cook, Stephane
    Weilenmann, Daniel
    Kaiser, Christoph
    Cuculi, Florim
    Valgimigli, Marco
    Juni, Peter
    Windecker, Stephan
    Pilgrim, Thomas
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2019, 8 (22):
  • [37] 2-Year Clinical Follow-Up From the Randomized Comparison of Biolimus-Eluting Stents With Biodegradable Polymer and Sirolimus-Eluting Stents With Durable Polymer in Routine Clinical Practice
    Klauss, Volker
    Serruys, Patrick W.
    Pilgrim, Thomas
    Buszman, Pawel
    Linke, Axel
    Ischinger, Thomas
    Eberli, Franz
    Corti, Roberto
    Wijns, William
    Morice, Marie-Claude
    di Mario, Carlo
    van Geuns, Robert Jan
    van Es, Gerrit-Anne
    Kalesan, Bindu
    Wenaweser, Peter
    Jueni, Peter
    Windecker, Stephan
    JACC-CARDIOVASCULAR INTERVENTIONS, 2011, 4 (08) : 887 - 895
  • [38] Serial Changes of Neointimal Coverage Conditions and Characteristics are different between Sirolimus-Eluting Stents and Paclitaxel-Eluting Stents Implantation: Follow-Up Optical Coherence Tomography Study
    Nakamura, Daisuke
    Nishino, Masami
    Lee, Yasuharu
    Yoshimura, Takahiro
    Taniike, Masayuki
    Makino, Nobuhiko
    Kato, Hiroyasu
    Egami, Yasuyuki
    Shutta, Ryu
    Tanouchi, Jun
    Yamada, Yoshio
    CIRCULATION, 2011, 124 (21)
  • [39] Comparison of the Ultrathin Strut, Biodegradable Polymer Sirolimus-eluting Stent With a Durable Polymer Everolimus-eluting Stent in a Chinese Population: The Randomized BIOFLOW VI Trial
    Li, Chongjian
    Yang, Yuejin
    Han, Yaling
    Song, Dan
    Xu, Jing
    Guan, Changdong
    Gao, Runlin
    Garcia-Garcia, Hector M.
    Waksman, Ron
    Xu, Bo
    CLINICAL THERAPEUTICS, 2020, 42 (04) : 649 - +
  • [40] A new generation of biodegradable polymer-coated sirolimus-eluting stents for the treatment of coronary artery disease: final 5-year clinical outcomes from the CREATE study
    Han, Ya-Ling
    Zhang, Lei
    Yang, Li-Xia
    Liu, Hui-Liang
    Qu, Peng
    Li, Wei-Min
    Jiang, Tie-Min
    Li, Shu-Mei
    Jing, Quan-Min
    Zhang, Quan-Yu
    Xu, Bo
    Li, Yi
    Gao, Run-Lin
    EUROINTERVENTION, 2012, 8 (07) : 815 - 822